Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer
Pasquale Saggese(University of California, Los Angeles), Claudio Scafoglio(University of California, Los Angeles), Ramin Salehi‐Rad(University of California, Los Angeles), Linh M. Tran(University of California, Los Angeles), David Elashoff(University of California, Los Angeles), Tristan Grogan(University of California, Los Angeles), Bin Liu(University of California, Los Angeles), Steven M. Dubinett(University of California, Los Angeles), Camelia Dumitras(University of California, Los Angeles), C. Jiménez Martínez(University of California, Los Angeles), Raymond J. Lim(University of California, Los Angeles)
Cited by 7
Related Papers
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
|Nature Medicine|2010|338
Electrochemical Sensor for Multiplex Biomarkers Detection
|Clinical Cancer Research|2009|259
Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo
|The Journal of Immunology|2000|202
COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California
|JAMA Network Open|2021|187
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer
|Cell Reports Medicine|2024|111